Matthias Schwab

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Open Label Study for the Functional Characterization of Drug Metabolism and Transport

Phase 1

Completed

Conditions: Genotype-related Drug Metabolism

Interventions: Drug: Codeine
Drug: Midazolam
Drug: pravastatin
Drug: Talinolol
Drug: torsemide

First Posted Date: 2013-02-11

Last Posted Date: 2015-05-27

Lead Sponsor: Matthias Schwab

Target Recruit Count: 144

Registration Number: NCT01788254

Locations: 🇩🇪
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
🇩🇪
Abteilung Klinische Pharmakologie, Tübingen, Germany

Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine

Phase 1

Terminated

Conditions: Drug Metabolism, Poor, CYP2D6-RELATED

Interventions: Drug: Metoclopramide
Drug: Diphenhydramine

First Posted Date: 2011-02-04

Last Posted Date: 2016-05-13

Lead Sponsor: Matthias Schwab

Target Recruit Count: 49

Registration Number: NCT01289938

Locations: 🇩🇪
Abteilung Klinische Pharmakologie, UKT Tübingen, Tübingen, BW, Germany

Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing

Phase 4

Terminated

Conditions: Gastroesophageal Reflux

Interventions: Drug: omeprazole

First Posted Date: 2007-10-01

Last Posted Date: 2014-02-25

Lead Sponsor: Matthias Schwab

Target Recruit Count: 68

Registration Number: NCT00537732

Locations: 🇩🇪
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Baden-Württemberg, Germany

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy